Member Info for sharehunter3

SOME chunky buys building already for afternoon

Seaking ,a look at their July rns R & D ,nice range ,with the £ millions they making each week /month from global sales
also with their work with their Partnership with AZ, GSK & University of Cambridge in as in April rns
and that rns today

personly like the potential here ,like azn ,

think there be more than myself ,hoping if a take over is coming that not yet , with the news due share price likely to soon move up to a higher level ,personly do not want to see a take over until share price has rerated

also how a share price can move up again ,example ncyt was drifting now after that rns today ,looking like interest building there again

also news due on
2,000 patient clinical trial using Novacyt's near-patient testing system initiated in London care homes

some selling and taking profits ,dissappointed to see a bit of a dip today , that could change with more good news as seen at ncyt today with their rns , New test differentiates COVID-19 from common winter diseases
,will more news be seen here again soon ,or will more research rns at ffwd and see the potential

Elchagie ,think there many people who happy with their investment in azn

good to see now gone blue
while have not been watching as much today ,been distracted by the rns at ncyt
hoping for a strong afternoon at GSK

ANOTHER BLUE DAY , good to see ,
had planned to look in more today ,and not watch ncyt until Sepember as was thinking a good month there in September
then rns there today on, New test differentiates COVID-19 from common winter diseases
hoping for more god news here at nfc ,and this buying to continue

down some today ,
more news migjht be seen at any time ,
had not planned to watch ncyt until September rns there today onNew test differentiates COVID-19 from common winter diseases
news might be seen here soon again

Bungle66 ,had planned to come back in September ,as my thinking share price was due a rerate ,with the £millions ncyt
have coming in weekly/monthly from Global sales and manufactering ,my personel view the share price doue a move back up over £4 again or higher ,others will have their own views and do their own research

had thought strong afternoon likely ,like the buying this morning ,thinking how strong is afternoon likely to be ,
also good to see how much shsare price has moved up in France today
had planned to watch other shares today, now back watching ncyt

holding steady again today ,
watching ncyt currently with the rns today ,New test differentiates COVID-19 from common winter diseases
also hoping for more of a move up here soon at boot

slight dip this morning ,hoping afternoon might see move up ,
not watching as much today ,back watching ncyt with thier rns released on new test

ANOTHER BLUE DAY
only looking in had got distracted at ncyt with their rns on new test
good buying here again today at pfg , another strong day

moving back up again ,good to see
even the rns today at ncyt with their latest test ,
how helpful will that be for the airline industry

Some of us investors expected September to be a month for a move up with share price , good to see the news starting to be released already
especially waiting on US news ,and sales update
todays news ,think many expected after recent tweets ,how good to see ncyt starting to release rns again
roll on next rns ,if later today ,or some day soon

others will make their own investing decisions , not thinking this drop much more ,
thinking a bounce might be seen again in future weeks
covid 19 effect has been seen on airline industry as well as other business ,
if improved testing at air ports ,will hopefully see more airlines moving again

if another rns seen today , or in future days , will not surprise me personly ,now that ncyt have started to release news again

sales update

Thanks Bungle66,
with ncyt how they have built their Global distributors ,also continue to expand their global distributors
www.primerdesign.co.uk/about/distributors
as well as thier number of products , for a global market ,as well as their R & D as from 27th July rns
R&D highlights

· Launch of near-patient (mobile) testing, which comprises Novacyt's COVID-19 test, direct-to-PCR RNA extraction kit (Exsig™ Direct), and q16 and q32 instruments

· Launch of a saliva sampling type to support ease of patient sampling, lower levels of discomfort and demonstrate more reproducible data

· Development of a respiratory testing panel to diagnose and distinguish between influenza A&B, RSV and COVID-19. Launch expected during September 2020 for the 2020/21 flu season in the Northern hemisphere

· Development of a two-gene test to address markets employing this testing approach. Launch expected no later than September 2020

· Development, together with a partner, of a serology (antibody) test to detect past infection of COVID-19. Launch expected in Q4 2020